机译:Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation
National and Kapodistrian University of Athens School of Medicine,Athens University Hospital Attikon;
University of Cyprus Medical School;
Baylor Scott and White Research InstituteCentre d'Investigations Cliniques Plurithématique 1433 and Inserm U1116, CHRU, FCRIN INI‐CRCTMedical Department,Boehringer Ingelheim Norway KS, AskerBoehringer Ingelheim Pharma GmbH & Co. KGBoehringer Ingelheim International GmbHDepartment of Medical Statistics,London School of Hygiene & Tropical MedicineBaylor University Medical CenterDepartment of Cardiology (CVK) of German Heart Center Charité;
Institute of Health Center for;
Heart failure with preserved ejection fraction; Empagliflozin; Sodium–glucose cotransporter 2 inhibitor; Atrial fibrillation; Atrial flutter; Prognosis;